Updated on 2024/07/28

Information

 

写真a

 
ITO MAMORU
 
Organization
Faculty of Medical Sciences Department of Clinical Medicine Assistant Professor
School of Medicine Department of Medicine(Joint Appointment)
Title
Assistant Professor
External link

Papers

  • Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions

    Mamoru Ito, Michitaka Nakano, Hiroshi Ariyama, Kyoko Yamaguchi, Risa Tanaka, Yuichiro Semba, Takeshi Sugio, Kohta Miyawaki, Yoshikane Kikushige, Shinichi Mizuno, Taichi Isobe, Kenro Tanoue, Ryosuke Taguchi, Shohei Ueno, Takahito Kawano, Masaharu Murata, Eishi Baba, Koichi Akashi

    Cancer Letters   532   215597 - 215597   2022.4

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.canlet.2022.215597

  • Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer

    ( 8 )   2024.5

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    PURPOSE

    The impact of genomic alterations on response and resistance to trastuzumab deruxtecan (T-DXd) has not been elucidated. Thus, we sought to identify factors predicting sensitivity to T-DXd in gastric or gastroesophageal junction (G/GEJ) cancer.

    METHODS

    We conducted a retrospective study using real-world clinical data and next-generation sequencing–based comprehensive genomic profiling (CGP) data from patients with advanced G/GEJ cancers, collected by the nationwide database in Japan. We analyzed the associations between genomic alterations and the patients' survivals after T-DXd treatment.

    RESULTS

    In 114 patients with human epidermal growth factor receptor-2 (HER2)–positive G/GEJ cancer treated with T-DXd, the most frequently altered genes were TP53 (82&#37;), ERBB2 (80&#37;), and CCNE1 (36&#37;). Multivariate Cox regression analysis revealed CCNE1 amplification to be a significant predictor of shorter progression-free survival (PFS) after T-DXd treatment among 91 patients whose CGP samples were obtained before T-DXd (median PFS, 131 days v 189 days; hazard ratio [HR], 1.90 [95&#37; CI, 1.02 to 3.53]; P = .044). Analyses of 1,450 G/GEJ cancers revealed significant CCNE1/ ERBB2 coamplification (41&#37; relative to 11&#37; CCNE1 amplification in ERBB2-nonamplified tumors; P < .0001). ERBB2-activating mutations were also detected in 3.7&#37; of G/GEJ cancers and in 8.8&#37; of HER2-positive G/GEJ cancers treated with T-DXd. Patients with ERBB2-mutated tumors showed shorter PFS than those without ERBB2 mutations after T-DXd treatment (mPFS, 105 v 180 days; P = .046).

    CONCLUSION

    CCNE1 amplification may confer primary resistance to T-DXd in HER2-positive G/GEJ cancer, suggesting that the cell cycle could be a potential therapeutic target in CCNE1/ERBB2 coamplified tumors. ERBB2-activating mutation may also attenuate T-DXd efficacy in HER2-positive G/GEJ cancer.

    DOI: 10.1200/po.23.00681

  • Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology. Invited Reviewed International journal

    Mamoru Ito, Yuta Okumura, Kenta Nio, Eishi Baba, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Kenji Tsuchihashi

    International Journal of Clinical Oncology   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence

    Kuniko Sunami, Yoichi Naito, Yusuke Saigusa, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Keigo Komine, Takafumi Koyama, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Makoto Hirata, Mamoru Ito, Toshiyuki Kozuki, Hiroyuki Sakashita, Hidehito Horinouchi, Yusuke Okuma, Atsuo Takashima, Toshio Kubo, Shuichi Hironaka, Yoshihiko Segawa, Yoshihiro Yakushijin, Hideaki Bando, Akitaka Makiyama, Tatsuya Suzuki, Ichiro Kinoshita, Shinji Kohsaka, Yuichiro Ohe, Chikashi Ishioka, Kouji Yamamoto, Katsuya Tsuchihara, Takayuki Yoshino

    JAMA Oncology   10 ( 1 )   95 - 95   2024.1

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1001/jamaoncol.2023.5120

  • Homologous Recombination Repair Gene Alterations Are Associated with Tumor Mutational Burden and Survival of Immunotherapy. International journal

    Mamoru Ito, Makoto Kubo, Hitomi Kawaji, Yoshiki Otsubo, Kanako Kurata, Hikaru Abutani, Mikita Suyama, Yoshinao Oda, Tomoharu Yoshizumi, Masafumi Nakamura, Eishi Baba

    Cancers   15 ( 23 )   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/cancers15235608

  • Homologous Recombination Repair Gene Alterations Are Associated with Tumor Mutational Burden and Survival of Immunotherapy Reviewed International journal

    Mamoru Ito, Makoto Kubo, Hitomi Kawaji, Yoshiki Otsubo, Kanako Kurata, Hikaru Abutani, Mikita Suyama, Yoshinao Oda, Tomoharu Yoshizumi, Masafumi Nakamura, Eishi Baba

    Cancers   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/cancers15235608

  • Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

    Hirofumi Ohmura, Moe Kondo, Masato Uenomachi, Hiroshi Ariyama, Mamoru Ito, Kenji Tsuchihashi, Masahiro Ayano, Hiroaki Niiro, Koichi Akashi, Eishi Baba

    Frontiers in Oncology   13   2023.10

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.3389/fonc.2023.1260818

  • Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan

    Kenji Tsuchihashi, Mamoru Ito, Shuji Arita, Hitoshi Kusaba, Wataru Kusano, Takashi Matsumura, Takafumi Kitazono, Shohei Ueno, Ryosuke Taguchi, Tomoyasu Yoshihiro, Yasuhiro Doi, Kohei Arimizu, Hirofumi Ohmura, Tatsuhiro Kajitani, Kenta Nio, Michitaka Nakano, Kotoe Oshima, Shingo Tamura, Tsuyoshi Shirakawa, Hozumi Shimokawa, Keita Uchino, Fumiyasu Hanamura, Yuta Okumura, Masato Komoda, Taichi Isobe, Hiroshi Ariyama, Taito Esaki, Kazuki Hashimoto, Noritaka Komune, Mioko Matsuo, Keiji Matsumoto, Kaori Asai, Tadamasa Yoshitake, Hidetaka Yamamoto, Yoshinao Oda, Koichi Akashi, Eishi Baba

    BMC Cancer   23 ( 1 )   2023.10

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12885-023-11528-4

  • Intraosseous synovial sarcoma of the mandible: A case report and review of the literature. International journal

    Ikumi Imajo, Tomohiro Yamada, Toru Chikui, Tamotsu Kiyoshima, Mamoru Ito, Kenichi Kohashi, Eiji Sakamoto, Yoshinao Oda

    Oncology letters   26 ( 1 )   318 - 318   2023.7

     More details

    Language:English  

    DOI: 10.3892/ol.2023.13904

  • Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan

    Yoichi Naito, Kuniko Sunami, Hidenori Kage, Keigo Komine, Toraji Amano, Mitsuho Imai, Takafumi Koyama, Daisuke Ennishi, Masashi Kanai, Hirotsugu Kenmotsu, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Kousuke Watanabe, Hidekazu Shirota, Ichiro Kinoshita, Masashiro Yoshioka, Nobuaki Mamesaya, Mamoru Ito, Shinji Kohsaka, Yusuke Saigusa, Kouji Yamamoto, Makoto Hirata, Katsuya Tsuchihara, Takayuki Yoshino

    JAMA Network Open   5 ( 12 )   e2245081 - e2245081   2022.12

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1001/jamanetworkopen.2022.45081

  • IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolism. International journal

    Hitoshi Kusaba, Shohei Moriyama, Michinari Hieda, Mamoru Ito, Hirofumi Ohmura, Taichi Isobe, Kenji Tsuchihashi, Mitsuhiro Fukata, Hiroshi Ariyama, Eishi Baba

    Japanese journal of clinical oncology   52 ( 10 )   1183 - 1190   2022.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/jjco/hyac103

  • 希少がんの治療戦略 信頼と絆に基づく肉腫のチーム医療

    遠藤 誠, 土橋 賢司, 松本 嘉寛, 坂本 節子, 鍋島 央, 飯田 圭一郎, 藤原 稔史, 伊東 守, 磯部 大地, 有山 寛, 赤司 浩一, 馬場 英司, 中島 康晴

    日本癌治療学会学術集会抄録集   60回   WS15 - 3   2022.10

     More details

    Language:English  

  • Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.

    Kyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama, Mamoru Ito, Michitaka Nakano, Yuichiro Semba, Jumpei Nogami, Kenji Tsuchihashi, Takuji Yamauchi, Shohei Ueno, Taichi Isobe, Koji Shindo, Taiki Moriyama, Kenoki Ohuchida, Masafumi Nakamura, Yoshihiro Nagao, Tetsuo Ikeda, Makoto Hashizume, Hiroyuki Konomi, Takehiro Torisu, Takanari Kitazono, Tomohiro Kanayama, Hiroyuki Tomita, Yoshinao Oda, Hitoshi Kusaba, Takahiro Maeda, Koichi Akashi, Eishi Baba

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association   25 ( 5 )   862 - 878   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10120-022-01307-8

  • Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions Reviewed International journal

    Mamoru Ito, Michitaka Nakano, Hiroshi Ariyama, Kyoko Yamaguchi, Risa Tanaka, Yuichiro Semba, Takeshi Sugio, Kohta Miyawaki, Yoshikane Kikushige, Shinichi Mizuno, Taichi Isobe, Kenro Tanoue, Ryosuke Taguchi, Shohei Ueno, Takahito Kawano, Masaharu Murata, Eishi Baba, Koichi Akashi

    Cancer Letters   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.canlet.2022.215597

    Other Link: https://www.sciencedirect.com/science/article/pii/S0304383522000726?via%3Dihub

  • Alveolar soft part sarcoma of the orbit: A case report

    Takeshi Oda, Kazufumi Kikuchi, Osamu Togao, Shingo Baba, Masahiro Mizoguchi, Mika Tanabe, Mamoru Ito, Hidetaka Yamamoto, Kousei Ishigami, Akio Hiwatashi

    Radiology Case Reports   16 ( 12 )   3766 - 3771   2021.12

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.radcr.2021.09.005

  • Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients? International journal

    Eijiro Shimada, Makoto Endo, Yoshihiro Matsumoto, Kenji Tsuchihashi, Mamoru Ito, Hitoshi Kusaba, Akira Nabeshima, Tomoya Nawata, Akira Maekawa, Tomoya Matsunobu, Nokitaka Setsu, Toshifumi Fujiwara, Keiichiro Iida, Makoto Nakagawa, Takeshi Hirose, Masaya Kanahori, Ryunosuke Oyama, Taichi Isobe, Hiroshi Ariyama, Kenichi Kohashi, Hidetaka Yamamoto, Yoshinao Oda, Yukihide Iwamoto, Koichi Akashi, Eishi Baba, Yasuharu Nakashima

    Journal of clinical medicine   10 ( 21 )   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/jcm10214972

  • Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report. International journal

    Shohei Ueno, Masato Uenomachi, Hitoshi Kusaba, Mamoru Ito, Kunihiro Suzuki, Hirofumi Ohmura, Kenji Tsuchihashi, Hiroshi Ariyama, Koichi Akashi, Eishi Baba

    Molecular and clinical oncology   15 ( 4 )   221 - 221   2021.10

     More details

    Language:English  

    DOI: 10.3892/mco.2021.2379

  • [Development of Cancer Genomic Medicine in Kyushu Region and the Roles of Kyushu University Hospital as a Core Hospital for Cancer Genomic Medicine].

    Mamoru Ito, Eishi Baba

    Gan to kagaku ryoho. Cancer & chemotherapy   48 ( 7 )   873 - 877   2021.7

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

  • Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy: A case report. International journal

    Kyoko Yamaguchi, Kenji Tsuchihashi, Kunihiro Tsuji, Yosuke Kito, Kenro Tanoue, Hirofumi Ohmura, Mamoru Ito, Taichi Isobe, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba

    Medicine   100 ( 19 )   e25773   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MD.0000000000025773

  • Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab. International journal

    Kenro Tanoue, Shingo Tamura, Hitoshi Kusaba, Yudai Shinohara, Mamoru Ito, Kenji Tsuchihashi, Tsuyoshi Shirakawa, Taiga Otsuka, Hirofumi Ohmura, Taichi Isobe, Hiroshi Ariyama, Sakuya Koreishi, Yuzo Matsushita, Hozumi Shimokawa, Risa Tanaka, Kenji Mitsugi, Koichi Akashi, Eishi Baba

    Scientific reports   11 ( 1 )   2741 - 2741   2021.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-021-82448-1

  • Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin. International journal

    Kenji Tsuchihashi, Hitoshi Kusaba, Tomoyasu Yoshihiro, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Takashi Imajima, Yudai Shinohara, Mamoru Ito, Satoru Yamaga, Kenro Tanoue, Kohei Arimizu, Hirofumi Ohmura, Fumiyasu Hanamura, Kyoko Yamaguchi, Taichi Isobe, Hiroshi Ariyama, Yasuharu Nakashima, Koichi Akashi, Eishi Baba

    Scientific reports   10 ( 1 )   20896 - 20896   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-020-77898-y

  • RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells

    Nobuhiro Tsuruta, Kenji Tsuchihashi, Hirofumi Ohmura, Kyoko Yamaguchi, Mamoru Ito, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba

    Biochemical and Biophysical Research Communications   530 ( 1 )   235 - 239   2020.9

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2020.06.153

  • Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib

    Kenta Nio, Kenji Tsuchihashi, Keisuke Taguchi, Tomoyasu Yoshihiro, Kyoko Yamaguchi, Mamoru Ito, Shohei Moriyama, Mitsuhiro Fukata, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Yasuharu Nakashima, Takahiro Wakasaki, Ryuji Yasumatsu, Hiroshi Ariyama, Hitoshi Kusaba, Junji Kishimoto, Koichi Akashi, Eishi Baba

    INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY   5 ( 4 )   2020.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/IJ9.0000000000000089

  • FoundationOne CDxによる進行大腸癌患者の遺伝子変異解析

    倉田 加奈子, 久保 真, 永井 俊太郎, 藤田 逸人, 土橋 賢司, 有山 寛, 永吉 絹子, 貞苅 良彦, 川地 眸, 甲斐 昌也, 伊東 守, 山元 英崇, 小田 義直, 馬場 英司, 中村 雅史

    日本外科学会定期学術集会抄録集   120回   SF - 5   2020.8

     More details

    Language:Japanese  

  • OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody. International journal

    Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Mamoru Ito, Akitaka Makiyama, Keita Uchino, Hozumi Shimokawa, Shingo Tamura, Taito Esaki, Kenji Mitsugi, Yoshihiro Shibata, Hisanobu Oda, Kenji Tsuchihashi, Hiroshi Ariyama, Hitoshi Kusaba, Yoshinao Oda, Koichi Akashi, Eishi Baba

    British journal of cancer   122 ( 10 )   1507 - 1517   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41416-020-0810-1

  • Activation of memory/effector T cells and association between prognosis and OX40-positive T cells in advanced head and neck cancer patients treated with anti-programmed death-1 antibody.

    Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Tanoue Kenrou, Shiho Kawagoe, Kohei Arimizu, Yuzo Matsushita, Tatsuhiro Kajitani, Shingo Tamura, Hozumi Shimokawa, Keita Uchino, Hisanobu Oda, Yudai Shinohara, Mamoru Ito, Kenji Tsuchihashi, Taichi Isobe, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba

    Journal of Clinical Oncology   38 ( 5_suppl )   35 - 35   2020.2

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1200/jco.2020.38.5_suppl.35

  • Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer. International journal

    Hirofumi Ohmura, Mamoru Ito, Keita Uchino, Chihiro Okada, Shigeki Tanishima, Yuichi Yamada, Seiya Momosaki, Masato Komoda, Miyuki Kuwayama, Kyoko Yamaguchi, Yuta Okumura, Michitaka Nakano, Kenji Tsuchihashi, Taichi Isobe, Hiroshi Ariyama, Hitoshi Kusaba, Yoshinao Oda, Koichi Akashi, Eishi Baba

    FEBS open bio   10 ( 1 )   147 - 157   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/2211-5463.12765

  • Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.

    Tomoyasu Yoshihiro, Hitoshi Kusaba, Akitaka Makiyama, Kazuma Kobayashi, Masato Uenomachi, Mamoru Ito, Yasuhiro Doi, Kenji Mitsugi, Tomomi Aikawa, Kotoe Takayoshi, Taito Esaki, Hozumi Shimokawa, Kenji Tsuchihashi, Hiroshi Ariyama, Koichi Akashi, Eishi Baba

    International journal of clinical oncology   24 ( 5 )   508 - 515   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10147-018-01391-w

  • Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody.

    Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Mamoru Ito, Akitaka Makiyama, Keita Uchino, Hozumi Shimokawa, Taito Esaki, Kenji Mitsugi, Yoshihiro Shibata, Hisanobu Oda, Kenji Tsuchihashi, Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Eishi Baba

    Journal of Clinical Oncology   37 ( 4_suppl )   54 - 54   2019.2

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1200/jco.2019.37.4_suppl.54

  • Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer. International journal

    Michitaka Nakano, Yoshikane Kikushige, Kohta Miyawaki, Yuya Kunisaki, Shinichi Mizuno, Katsuto Takenaka, Shingo Tamura, Yuta Okumura, Mamoru Ito, Hiroshi Ariyama, Hitoshi Kusaba, Masafumi Nakamura, Takahiro Maeda, Eishi Baba, Koichi Akashi

    Oncogene   38 ( 6 )   780 - 793   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41388-018-0480-0

  • Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer. International journal

    Kenji Tsuchihashi, Mamoru Ito, Toshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi, Atsuo Takashima, Yosuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Taito Esaki, Akitaka Makiyama, Tadamichi Denda, Hironaga Satake, Takeshi Suto, Naotoshi Sugimoto, Kenji Katsumata, Toshiaki Ishikawa, Tomomi Kashiwada, Eiji Oki, Yoshito Komatsu, Hiroyuki Okuyama, Daisuke Sakai, Hideki Ueno, Takao Tamura, Kimihiro Yamashita, Junji Kishimoto, Yasuhiro Shimada, Eishi Baba

    Clinical colorectal cancer   17 ( 4 )   e687-e697   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.clcc.2018.07.004

  • Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer. International journal

    Michitaka Nakano, Mamoru Ito, Risa Tanaka, Hiroshi Ariyama, Kenji Mitsugi, Akitaka Makiyama, Keita Uchino, Taito Esaki, Nobuhiro Tsuruta, Fumiyasu Hanamura, Kyoko Yamaguchi, Yuta Okumura, Kosuke Sagara, Kotoe Takayoshi, Kenta Nio, Kenji Tsuchihashi, Shingo Tamura, Hozumi Shimokawa, Shuji Arita, Kohta Miyawaki, Hitoshi Kusaba, Koichi Akashi, Eishi Baba

    Cancer science   109 ( 11 )   3461 - 3470   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cas.13777

  • The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer. International journal

    Kyoko Yamaguchi, Hitoshi Kusaba, Akitaka Makiyama, Kenji Mitsugi, Keita Uchino, Shingo Tamura, Yoshihiro Shibata, Taito Esaki, Mamoru Ito, Kotoe Takayoshi, Kenji Tsuchihashi, Shuji Arita, Hiroshi Ariyama, Koichi Akashi, Eishi Baba

    Cancer chemotherapy and pharmacology   82 ( 4 )   625 - 633   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00280-018-3652-2

  • Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody. International journal

    Kyoko Yamaguchi, Koji Mishima, Hirofumi Ohmura, Fumiyasu Hanamura, Mamoru Ito, Michitaka Nakano, Kenji Tsuchihashi, Shun-Ichiro Ota, Naoko Wada, Hiroshi Uchi, Hiroshi Ariyama, Hitoshi Kusaba, Hiroaki Niiro, Koichi Akashi, Eishi Baba

    Cancer science   109 ( 10 )   3032 - 3042   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cas.13758

  • PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer. International journal

    Michitaka Nakano, Mamoru Ito, Risa Tanaka, Kyoko Yamaguchi, Hiroshi Ariyama, Kenji Mitsugi, Tomoyasu Yoshihiro, Hirofumi Ohmura, Nobuhiro Tsuruta, Fumiyasu Hanamura, Kosuke Sagara, Yuta Okumura, Kenta Nio, Kenji Tsuchihashi, Shuji Arita, Hitoshi Kusaba, Koichi Akashi, Eishi Baba

    Cancer science   109 ( 9 )   2986 - 2992   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cas.13723

  • A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy. International journal

    Hozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, Kenta Nio, Kyoko Inadomi, Kotoe Takayoshi, Mamoru Ito, Shingo Tamura, Akitaka Makiyama, Chinatsu Makiyama, Gen Hirano, Yoshihiro Shibata, Tsuyoshi Shirakawa, Kenji Mitsugi, Hiroshi Ariyama, Taito Esaki, Koichi Akashi, Eishi Baba

    Medicine   97 ( 25 )   e11042   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MD.0000000000011042

  • Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer. International journal

    Mamoru Ito, Hitoshi Kusaba, Satomi Mukaide, Junji Kishimoto, Hozumi Shimokawa, Shingo Tamura, Akitaka Makiyama, Gen Hirano, Hisanobu Oda, Tsuyoshi Shirakawa, Masato Komoda, Keita Uchino, Risa Tanaka, Kenji Mitsugi, Taito Esaki, Shuji Arita, Hiroshi Ariyama, Koichi Akashi, Eishi Baba

    Anti-cancer drugs   28 ( 10 )   1166 - 1173   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/CAD.0000000000000562

  • Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report. International journal

    Tomoyasu Yoshihiro, Kenta Nio, Kenji Tsuchihashi, Hiroshi Ariyama, Kenichi Kohashi, Nobuhiro Tsuruta, Fumiyasu Hanamura, Kyoko Inadomi, Mamoru Ito, Kosuke Sagara, Yuta Okumura, Michitaka Nakano, Shuji Arita, Hitoshi Kusaba, Yoshinao Oda, Koichi Akashi, Eishi Baba

    Molecular and clinical oncology   6 ( 6 )   866 - 870   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/mco.2017.1240

  • Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans. International journal

    Kenji Tsuchihashi, Hitoshi Kusaba, Yuichi Yamada, Yuta Okumura, Hozumi Shimokawa, Masato Komoda, Keita Uchino, Tomoyasu Yoshihiro, Nobuhiro Tsuruta, Fumiyasu Hanamura, Kyoko Inadomi, Mamoru Ito, Kosuke Sagara, Michitaka Nakano, Kenta Nio, Shuji Arita, Hiroshi Ariyama, Kenichi Kohashi, Ryuji Tominaga, Yoshinao Oda, Koichi Akashi, Eishi Baba

    Molecular and clinical oncology   6 ( 5 )   665 - 668   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/mco.2017.1197

▼display all

MISC

  • 切除不能進行・再発腺様嚢胞癌(ACC)に対するニボルマブの有効性および安全性の後方視的検討

    上ノ町 優仁, 上野 翔平, 近藤 萌, 伊東 守, 土橋 賢司, 有山 寛, 草場 仁志, 馬場 英司, 田中 吏佐, 三ツ木 健二

    日本内科学会雑誌   2019.2

     More details

    Language:Japanese  

  • 腔水症検体を用いたTAMからCAFへの分化機構の解明(Macrophages in ascites from cancer patients are primed to transdifferentiate into fibroblasts)

    伊東 守, 中野 倫孝, 有山 寛, 山口 享子, 仙波 雄一郎, 杉尾 健志, 宮脇 恒太, 菊繁 吉謙, 水野 晋一, 田中 吏佐, 馬場 英司, 赤司 浩一

    日本癌学会総会記事   2018.9

     More details

    Language:English  

Research Projects

  • 消化器癌微小環境のマクロファージ-線維芽細胞分化転換を阻害する新規治療標的の探索

    Grant number:23K19512  2023 - 2024

    日本学術振興会  科学研究費助成事業  研究活動スタート支援

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding